glp 1 drugs and ulcerative colitis Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential GLP-1s and Ulcerative Colitis: Safety

For some patients, GLP-1 microdosing might work, but for others it might not be a realistic option

Navigating GLP-1 Options: A Guide to Empowered Discussions with Your Healthcare Provider How to Discuss GLP-1 Options with Your Healthcare Provider

4 Challenges and future directions 4.1 Safety considerations The safety profile of dual or triple receptor agonists targeting GLP-1, GIP, and GCG receptors in the treatment of MASLD and related metabolic disorders warrants careful evaluation

Daniel McGee, Board-certified Family Medicine Physician When Discomfort Becomes a Danger Zone While many of the GI side effects we discussed above are common, some more adverse effects are not and could have serious complications

Rare but serious side effects include pancreatitis, gallbladder problems, and kidney issues

Kivimki, M